Dr. Shoemaker and Autism WAS Re: VIP

[Guest guest]

I am still in the beginning stages of reading this book. His idea to loosen up

biofilm in the sinus cavity is huge I feel. No one is addressing this part. The

sinus is so close to the brain, I could see where this would be a big problem

for many autistics. My son has autism and is doing very very well with several

things. Right now we have mostly ocd about doors at the moment, but very

conversational. Chelation is a big part of getting well. We use Andy Cutlers

protocol. But also, RS's ideas sound very plausible even if there is no mold.

It's about biotoxins. Which he also mentions come from waterways as well. Just

the binder alone could do alot to bring inflammation down from toxic load. There

are so many factors to look for in treating autism and inflammation. I believe

the biggest is getting blood circulating well into the small veins to the organs

which are constricted from who knows what. Too much seratonin does this as well.

You could look into his fees and see if he's taking patients or ask about autism

treatment recommendations in general.

jenib

> > > > >>

> > > > >> Vasoactive intestinal peptide (VIP) is a peptide hormone containing

28

> > > amino acid residues and is produced in many areas of the human body

> > > including the gut, pancreas, and suprachiasmatic nuclei of the

hypothalamus

> > > in the brain. VIP acts as hormones, neurotransmitters, immune modulators

and

> > > neurotrophes in the body. Dr. RS recently started recommending low dose of

> > > VIP in the form of nasal spray for treating systemic inflammation response

> > > syndrome. In the gut, VIP stimulates pancreatic bicarbonates secretion. In

> > > the brain, VIP plays a key role in communication between individual brain

> > > cells.

> > > > >>

> > > > >> Immunomodulation of innate immune responses by vasoactive intestinal

> > > peptide (VIP): its therapeutic potential in inflammatory disease:

> > > > >> http://www.ncbi.nlm.nih.gov/pubmed/19604262

> > > > >>

> > > > >> The significance of vasoactive intestinal peptide in

immunomodulation:

> > > > >> http://pharmrev.aspetjournals.org/content/56/2/249.short

> > > > >>

> > > > >> Is chronic fatigue syndrome an autoimmune disorder o endogenous

> > > neuropeptides, exogenous infection and molecular mimicry?

> > > > >> http://cfids-cab.org/cfs-inform/MitochondrialATP/staines04.pdf

> > > > >>

> > > > >> Limin

> > > > >>

> > > > >

> > > > >

> > > > >

> > > > >

> > > > > ------------------------------------

> > > > >

> > > > >